MARINUS PHARMACEUTICALS, INC. Annual Operating Income (Loss) in USD from 2013 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2023.
  • Marinus Pharmaceuticals, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$32.2M, a 2.54% decline year-over-year.
  • Marinus Pharmaceuticals, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$135M, a 9.24% decline year-over-year.
  • Marinus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2023 was -$131M, a 16.6% decline from 2022.
  • Marinus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2022 was -$113M, a 16.4% decline from 2021.
  • Marinus Pharmaceuticals, Inc. annual Operating Income (Loss) for 2021 was -$96.9M, a 42.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$131M -$18.7M -16.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 -$113M -$15.9M -16.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 -$96.9M -$29M -42.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$67.9M -$13.5M -24.8% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-24
2019 -$54.4M -$17.2M -46.4% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 -$37.2M -$18.1M -95.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 -$19M +$9.2M +32.6% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
2016 -$28.2M -$3.81M -15.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-12
2015 -$24.4M -$12.5M -105% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-07
2014 -$11.9M -$6.54M -122% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-13
2013 -$5.38M Jan 1, 2013 Dec 31, 2013 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.